Production & Manufacturing

JHP Pharmaceuticals signs multi-year manufacturing contract

PBR Staff Writer Published 01 March 2012

JHP Pharmaceuticals has established a multi-year manufacturing contract with an undisclosed pharmaceutical company.

The company will be responsible for manufacturing and supply of an injectable anesthetic agent.

JHP president and CEO Stuart Hinchen said the company successfully completed an FDA (CBER) Pre-Approval Inspection in support of a biologic product launch for another long-term contract customer.

"Customers also rely on our extensive experience working with products throughout their life cycle which results in continuity of supply and program efficiencies," Hinchen added.